Incorrect pharmacokinetic information
for the Lantus insulin in Mosby's Nursing Drug Reference 2002
There is an error in the 2002 Mosby's Nursing Drug Reference.
On page 1014, in a monograph on insulin aspart (NOVOLOG)
and insulin glargine (LANTUS), the "pharmacokinetics" information on the two products was switched inadvertently.
Lantus is listed as having rapid onset and short duration while
NovoLog is listed as having a 24-hour duration.
